These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Using light to treat age-related macular degeneration. Nosek J Nurs Times; 2005 Nov 15-21; 101(46):30-3. PubMed ID: 16315801 [TBL] [Abstract][Full Text] [Related]
15. Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab. Barbazetto I; Saroj N; Shapiro H; Wong P; Freund KB Retina; 2010 Oct; 30(9):1376-85. PubMed ID: 20683380 [TBL] [Abstract][Full Text] [Related]
16. [Improved therapeutic possibilities of age-related macular degeneration. The Danish Society of Ophthalmology]. Hansen MH; Mortensen KK; Sjølie AK Ugeskr Laeger; 2003 Mar; 165(12):1249. PubMed ID: 12701299 [No Abstract] [Full Text] [Related]
17. Photodynamic therapy for age-related macular degeneration. Franks W Age Ageing; 2002 Jan; 31(1):5-6. PubMed ID: 11850299 [No Abstract] [Full Text] [Related]
18. Risks of adverse events with therapies for age-related macular degeneration: a response. Williams T; Reeves BC; Foss AJ; Fell G Arch Ophthalmol; 2012 Jan; 130(1):124-5; author reply 125-6. PubMed ID: 22232487 [No Abstract] [Full Text] [Related]
19. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration. Fine SL Arch Ophthalmol; 1999 Oct; 117(10):1400-2. PubMed ID: 10532450 [No Abstract] [Full Text] [Related]
20. Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration. Mete A; Saygili O; Mete A; Bayram M; Bekir N J Clin Ultrasound; 2010 Feb; 38(2):66-70. PubMed ID: 19953626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]